GlassScriptPhysician profile
Melissa A Reisinger
NPI 1831194406
$4,866.53
in general payments reported to CMS, 2019-2025
39 companies · $522 in 2025
The $522 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $435 · 2021: $760 · 2022: $636 · 2023: $1,298 · 2024: $627 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,447.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $899.17 | 2019-2025 | |
| Biogen, INC. | $435.28 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $363.58 | 2023-2025 | Myfembree, Gemtesa |
| Daiichi Sankyo INC. | $326.47 | 2020-2023 | Injectafer |
| Pfizer INC. | $287.51 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $210.32 | 2021-2025 | |
| Avion Pharmaceuticals | $206.32 | 2020-2023 | Balcoltra |
| Aspira Women'S Health INC | $199.48 | 2023 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $157.43 | 2019-2025 | |
| Astellas Pharma US INC | $153.74 | 2020-2025 | Veozah |
| Shield Therapeutics INC | $148.87 | 2022-2025 | Accrufer |
| Medical Device Business Services, INC. | $143.95 | 2019-2022 | |
| Myovant Sciences INC. | $143.80 | 2021-2022 | |
| Medtronic, INC. | $136.96 | 2023-2025 | V-Loc 180, Ligasure |
| Amgen INC. | $127.40 | 2019-2023 | Prolia, Evenity |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $124.32 | 2021-2023 | Twirla |
| Hologic Sales and Service, LLC | $90.89 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Ascend Therapeutics US, LLC | $74.55 | 2022-2023 | |
| Ethicon US, LLC | $72.09 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $67.66 | 2019-2023 | Gardasil 9 |
| Novo Nordisk INC | $61.58 | 2023 | Wegovy |
| Allergan, INC. | $57.08 | 2019 | |
| Sage Therapeutics, LLC | $54.69 | 2022-2023 | |
| Organon LLC | $39.93 | 2021-2025 | Nexplanon |
| Pacira Pharmaceuticals Incorporated | $36.05 | 2020-2024 | Exparel |
| Gynesonics, INC. | $32.14 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Duchesnay USA Incorporated | $31.31 | 2019 | |
| Therapeuticsmd, INC. | $23.06 | 2020 | |
| Vertical Pharmaceuticals, LLC | $22.11 | 2019 | |
| Covidien LP | $21.52 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.26 | 2025 | Xifaxan |
| Exeltis, USA INC. | $15.46 | 2024 | Slynd |
| Avanos Medical | $13.85 | 2023 | On-Q* Pump and Accessories |
| Olympus America INC. | $13.26 | 2019 | |
| Urovant Sciences INC | $13.02 | 2022 | |
| Exact Sciences Corporation | $12.86 | 2023 | Cologuard Collection Kit |
| Inari Medical, INC. | $11.83 | 2022 | |
| Scynexis, INC. | $11.53 | 2021 | |
| Meditrina | $8.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Reisinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.